Evidence map›Paper›PMID 35000578›Full record

ArticleBMC public health2022

Premature mortality attributable to COVID-19: potential years of life lost in 17 countries around the world, January-August 2020.

Maider Pagola Ugarte, Souzana Achilleos, Annalisa Quattrocchi, John Gabel, Ourania Kolokotroni, Constantina Constantinou, Nicoletta Nicolaou, Jose Manuel Rodriguez-Llanes, Qian Huang, Olesia Verstiuk and 29 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 4 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 4 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 19 institutions in 17 countries.

Maider Pagola Ugarte *University of Nicosia Medical School, Nicosia, Cyprus.
Souzana Achilleos *Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus. achilleos.s@unic.ac.cy.ORCID 0000-0002-1688-9225
Annalisa QuattrocchiDepartment of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.
John GabelUniversity of Nicosia Medical School, Nicosia, Cyprus.
Ourania KolokotroniDepartment of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.
Constantina ConstantinouDepartment of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia, Cyprus.
Nicoletta NicolaouDepartment of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia, Cyprus.
Jose Manuel Rodriguez-LlanesEuropean Commission Joint Research Centre, Ispra, Italy.
Qian HuangSouth Carolina Center for Rural and Primary Healthcare, Department of Geography, University of South Carolina, Columbia, USA.
Olesia VerstiukFaculty of Medicine 2, Bogomolets National Medical University, Kyiv, Ukraine.
Nataliia PidmurniakFaculty of Medicine 2, Bogomolets National Medical University, Kyiv, Ukraine.
Jennifer Wenjing TaoDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Bo BurströmDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Petra KlepacDepartment Communicable Diseases, National Institute of Public Health, Ljubljana, Slovenia.
Ivan ErzenPublic Health School, National Institute of Public Health, Ljubljana, Slovenia.
Mario ChongFacultad de Ingenieria, Universidad del Pacifico, Lima, Peru.
Manuel BarronDepartamento de Economia, Universidad del Pacifico, Lima, Peru.
Terje P HagenDepartment of Health Management and Economics, University of Oslo, Oslo, Norway.
Zhanna KalmatayevaFaculty of Medicine, Al Farabi Kazakh National University, Almaty, Kazakhstan.
Kairat DavletovHealth Research Institute, Al Farabi Kazakh National University, Almaty, Kazakhstan.
Inbar ZuckerIsrael Center for Disease Control, Ministry of Health, Ramat Gan, Israel.
Zalman KaufmanIsrael Center for Disease Control, Ministry of Health, Ramat Gan, Israel.
Maia KereselidzeNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Levan KandelakiNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Nolwenn Le MeurUniversity of Rennes, EHESP, REPERES - EA 7449, F-35000, Rennes, France.
Lucy GoldsmithPopulation Health Research Institute and Institute for Infection and Immunity, St George's, University of London, London, UK.
Julia A CritchleyPopulation Health Research Institute, St George's, University of London, London, UK.
Maria Angelica PinillaFaculty of Medicine, Universidad Cooperativa de Colombia, Villavicencio, Colombia.
Gloria Isabel JaramilloFaculty of Medicine, Universidad Cooperativa de Colombia, Villavicencio, Colombia.
Domingos TeixeiraMinistry of Health and Social Security, Praia, Cape Verde.
Lara Ferrero GomézDepartment of Nature, Life and Environment Sciences, Jean Piaget University of Cape Verde, Praia, Cape Verde.
Jackeline LobatoDepartment of Epidemiology and Biostatistics, Institute of Collective Health (ISC), Fluminense Federal University, Niterói, Brazil.
Carolina AraújoGraduate Public Health Program, Institute of Studies in Collective Health (IESC), Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Joseph CuthbertsonMonash University Disaster Resilience Initiative, Monash University, Melbourne, Australia.
Catherine M BennettInstitute for Health Transformation, Deakin University, Burwood, Australia.
Antonis PolemitisUniversity of Nicosia, Nicosia, Cyprus.
Andreas CharalambousUniversity of Nicosia Medical School, Nicosia, Cyprus.
Christiana A DemetriouDepartment of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.
C-MOR consortium
University of Nicosia · CYAl-Farabi Kazakh National University · KZBogomolets National Medical University · UAIsrael Ministry of Health · ILKarolinska Institutet · SENational Center for Disease Control and Public Health · GENational Institute of Public Health · SISt George's, University of London · GBUniversidad Cooperativa de Colombia · COUniversity of the Pacific · PEDeakin University · AUÉcole des Hautes Études en Santé Publique · FRJean Piaget University of Cape Verde · CVJoint Research Centre · ITMonash University · AUUniversidade Federal do Rio de Janeiro · BRUniversidade Federal Fluminense · BRUniversity of Oslo · NOUniversity of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding the impact of the burden of COVID-19 is key to successfully navigating the COVID-19 pandemic. As part of a larger investigation on COVID-19 mortality impact, this study aims to estimate the Potential Years of Life Lost (PYLL) in 17 countries and territories across the world (Australia, Brazil, Cape Verde, Colombia, Cyprus, France, Georgia, Israel, Kazakhstan, Peru, Norway, England & Wales, Scotland, Slovenia, Sweden, Ukraine, and the United States [USA]).

methodsAge- and sex-specific COVID-19 death numbers from primary national sources were collected by an international research consortium. The study period was established based on the availability of data from the inception of the pandemic to the end of August 2020. The PYLL for each country were computed using 80 years as the maximum life expectancy.

resultsAs of August 2020, 442,677 (range: 18-185,083) deaths attributed to COVID-19 were recorded in 17 countries which translated to 4,210,654 (range: 112-1,554,225) PYLL. The average PYLL per death was 8.7 years, with substantial variation ranging from 2.7 years in Australia to 19.3 PYLL in Ukraine. North and South American countries as well as England & Wales, Scotland and Sweden experienced the highest PYLL per 100,000 population; whereas Australia, Slovenia and Georgia experienced the lowest. Overall, males experienced higher PYLL rate and higher PYLL per death than females. In most countries, most of the PYLL were observed for people aged over 60 or 65 years, irrespective of sex. Yet, Brazil, Cape Verde, Colombia, Israel, Peru, Scotland, Ukraine, and the USA concentrated most PYLL in younger age groups.

conclusionsOur results highlight the role of PYLL as a tool to understand the impact of COVID-19 on demographic groups within and across countries, guiding preventive measures to protect these groups under the ongoing pandemic. Continuous monitoring of PYLL is therefore needed to better understand the burden of COVID-19 in terms of premature mortality.

Indexed as

COVID-19AgedBrazilFemaleHumansLife ExpectancyMaleMortalityMortality, PrematurePandemicsSARS-CoV-2United StatesCOVID-19Disease burdenPandemicPotential years of life lostPYLLSARS-CoV-2

Identifiers

PMID35000578
PMCPMC8743065
OpenAlexW4225818176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.